# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Argus Research analyst Chris Graja maintains CVS Health (NYSE:CVS) with a Buy and lowers the price target from $100 to $80.
Wells Fargo analyst Stephen Baxter maintains CVS Health (NYSE:CVS) with a Equal-Weight and lowers the price target from $76 ...
TD Cowen analyst Charles Ryhee downgrades CVS Health (NYSE:CVS) from Buy to Hold and lowers the price target from $99 to $59.
15 large-cap stocks had a rough week, with CVS, Starbucks, and DoorDash all taking major hits. Analysts have lowered price targ...
B of A Securities analyst Michael Cherny maintains CVS Health (NYSE:CVS) with a Buy and lowers the price target from $95 to ...